Company: SGBAF
Filing Date: 2025-01-17
Form Type: DRS/A
Source: 0000950123-25-000378
Chunk: 237

Company: SES S.A.
Filing Date: 2025-01-17
Form: DRS/A
Chunk 237
---
 |     | the U.S. judgment must relate to a private matter (i.e., be of a civil or commercial nature) and must not be 
 contrary to Luxembourg’s international public policy, as interpreted under Luxembourg law;                   |

| • |     | the U.S. judgment must not have been rendered as a result of or in connection with an evasion of Luxembourg law 
 (“fraude à la loi”); and                                                                                        |

| • |     | there is no contradiction between the U.S. judgment and an already issued judgment of a Luxembourg court. |

In addition, actions brought in a Luxembourg court against SES or the members of the SES Board, its other officers and the experts named herein to enforce liabilities based on U.S. federal securities laws may be subject to certain restrictions. In particular, Luxembourg courts do not award punitive damages. Litigation in Luxembourg is subject to rules of procedure that differ from U.S. rules, including with respect to the taking and admissibility of evidence, the conduct of the proceedings and the allocation of costs. Proceedings in Luxembourg would have to be conducted in the French or German language, and all procedural documents submitted to the court are required to be drafted in or to be translated into French or German. For these reasons, it may be difficult for a U.S. investor to bring an original action in a Luxembourg court predicated upon the civil liability provisions of the U.S. federal securities laws against SES, the members of the SES Board and other executive officers. In addition, even if a judgment against SES, the non-U.S.members of its Board, senior management, or the experts named in this prospectus based on the civil liability provisions of the U.S. federal securities laws is obtained, a U.S. investor may not be able to enforce it in U.S. or Luxembourg courts. 164

Confidential Treatment Requested by SES

Pursuant to 17 C.F.R. Section 200.83

LEGAL MATTERS

The validity of the CVRs to be issued to Intelsat in connection with the Acquisition will be passed upon for SES by Gibson, Dunn &
Crutcher LLP.

EXPERTS

The financial statements of SES as of December 31, 2023 and December 31, 2022 and for each of the two years in the period ended
December 31, 2023 included in this registration statement have been so included in reliance on the report of PricewaterhouseCoopers, Société coopérative, an independent registered public accounting firm